C301-2733 Screening compound: 5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1,3,4-oxadiazole-2-carboxamide

C301-2733 Screening compound: 5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1,3,4-oxadiazole-2-carboxamide
C301-2733 Screening compound: 5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1,3,4-oxadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-2733
5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1,3,4-oxadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-2733

Molecular Formula

C23H24Cl2FN5O2 (C23 H24 Cl2 FN5 O2)

Compound Name

5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-1,3,4-oxadiazole-2-carboxamide

IUPAC name

5-[(2-chloro-4-fluorophenyl)methyl]-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-134-oxadiazole-2-carboxamide

SMILES

O=C(c1nnc(Cc(ccc(F)c2)c2Cl)o1)NCCCN(CC1)CCN1c1cc(Cl)ccc1

InChI

InChI=1S/C23H24Cl2FN5O2/c24-17-3-1-4-19(14-17)31-11-9-30(10-12-31)8-2-7-27-22(32)23-29-28-21(33-23)13-16-5-6-18(26)15-20(16)25/h1,3-6,14-15H,2,7-13H2,(H,27,32)

InChI Key

MLFCDDDXKNPCCY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14742757

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.872

Distribution Coefficient, logD

3.329

Water Solubility, LogSw

-4.24

Polar Surface Area

61.917

Acid Dissociation Constant (pKa)

14.21

Base Dissociation Constant (pKb)

7.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

C301-2733 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C301-2733 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-2733?
Check Price and Availability of C301-2733, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-2733 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-2733
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-2733
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-2733 available by request